Martin Pule

24PUBLICATIONS
140CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 01, 2026
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

|Apr 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.

Nicola Maciocia, Malika Hoekx, Ciaran Acuna

|Nov 11, 2024
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.

Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli

|Feb 21, 2024
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.

Mathieu Ferrari, Matteo Righi, Vania Baldan

|Sep 14, 2023
AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival.

Vedika Mehra, Giulia Agliardi, Juliana Dias Alves Pinto

|Aug 30, 2023
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.

Sara Ghorashian, Giovanna Lucchini, Rachel Richardson

Pageof 4

Frequent Collaborators

7 joint publications

Paul Maciocia

7 joint publications

Mathieu Ferrari

5 joint publications

Sara Ghorashian

4 joint publications

Persis J Amrolia